Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:35 AM
Ignite Modification Date:
2025-12-25 @ 12:35 AM
NCT ID:
NCT00572767
Eligibility Criteria:
Inclusion Criteria:
* patients after first-ever ischemic stroke with a clinical relevant paresis of the upper and lower limb (general clinical muscle testing below level four)
* correlation of clinical symptoms with a brain imaging (CT or MRI)
* able to communicate with the neurological examiner and understand the aim/matter of the study (with or without aphasia)
* start of the first oral application of the study drug between the fourteenth and 60th day after stroke onset
* older than 13 years
* given written informed consent (or two independent witnesses)
Exclusion Criteria:
* intracranial or (chronic) subdural hemorrhages
* any additional neurological or psychiatric illnesses
* instable arrythmia
* not controlled or treated arterial hypertension
* ensured cardioembolic event
* anxiolytica, neuroleptica, or alpha-adrenergic antagonists or agonists respectively
* certain anticonvulsiva or antihypertonica
* manifest hyperthyreosis
* dementia or terminal illnesses
* epilepsy, phaeochromocytoma or glaucoma
* women known to be pregnant or lactating
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00572767
Study Brief:
Protocol Section:
NCT00572767